Skip to Content

Oritavancin

In the US, Oritavancin (oritavancin systemic) is a member of the drug class glycopeptide antibiotics and is used to treat Skin and Structure Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01XA05

CAS registry number (Chemical Abstracts Service)

0171099-57-3

Chemical Formula

C86-H97-Cl3-N10-O26

Molecular Weight

1793

Therapeutic Category

Glycopeptide antibacterial

Chemical Name

(4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-arabino-hexopyranosyl)-N³ ' '-[p-(p-chlorophenyl)benzyl]vancomycin (WHO)

Foreign Names

  • Oritavancinum (Latin)
  • Oritavancin (German)
  • Oritavancine (French)
  • Oritavancina (Spanish)

Generic Names

  • Oritavancin (OS: USAN)
  • LY333328 (IS)
  • UNII-PUG62FRZ2E (IS)
  • Oritavancin Diphosphate (OS: USAN)
  • LY333328 diphosphate (IS)
  • UNII-VL1P93MKZN (IS)

Brand Names

  • Orbactiv
    The Medicines Company, Ireland; The Medicines Company UK, United Kingdom; The Medicines Company, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide